A decline in activities of daily living due to acute heart failure is an independent risk factor of hospitalization for heart failure and mortality.


Journal

Journal of cardiology
ISSN: 1876-4738
Titre abrégé: J Cardiol
Pays: Netherlands
ID NLM: 8804703

Informations de publication

Date de publication:
06 2019
Historique:
received: 21 08 2018
revised: 24 10 2018
accepted: 05 12 2018
pubmed: 2 1 2019
medline: 26 5 2020
entrez: 2 1 2019
Statut: ppublish

Résumé

Although activities of daily living (ADL) are recognized as being pertinent in averting relevant readmission of heart failure (HF) and mortality, little research has been conducted to assess a correlation between a decline in ADL and outcomes in HF patients. The Kitakawachi Clinical Background and Outcome of Heart Failure Registry is a prospective, multicenter, community-based cohort of HF patients. We categorized the patients into four types of ADL: independent outdoor walking, independent indoor walking, indoor walking with assistance, and abasia. We defined a decline in ADL (decline ADL) as downgrade of ADL and others (non-decline ADL) as preservation of ADL before discharge compared with admission. Among 1253 registered patients, 923 were eligible, comprising 98 (10.6%) with decline ADL and 825 (89.4%) with non-decline ADL. Decline ADL exhibited a higher risk of hospitalization for HF and mortality compared with non-decline ADL. A multivariate analysis revealed that decline ADL emerged as an independent risk factor of hospitalization for HF [hazard ratio (HR), 1.42; 95% confidence interval (CI): 1.01-1.96; p=0.046] and mortality (HR, 1.95; 95% CI: 1.23-2.99; p<0.01). Although 66.3% of patients with decline ADL were registered for long-term care insurance, few received daycare services (32.7%) or home-visit medical services (8.2%). Decline in ADL is a predictor of hospitalization for HF and mortality in HF patients.

Sections du résumé

BACKGROUND
Although activities of daily living (ADL) are recognized as being pertinent in averting relevant readmission of heart failure (HF) and mortality, little research has been conducted to assess a correlation between a decline in ADL and outcomes in HF patients.
METHODS
The Kitakawachi Clinical Background and Outcome of Heart Failure Registry is a prospective, multicenter, community-based cohort of HF patients. We categorized the patients into four types of ADL: independent outdoor walking, independent indoor walking, indoor walking with assistance, and abasia. We defined a decline in ADL (decline ADL) as downgrade of ADL and others (non-decline ADL) as preservation of ADL before discharge compared with admission.
RESULTS
Among 1253 registered patients, 923 were eligible, comprising 98 (10.6%) with decline ADL and 825 (89.4%) with non-decline ADL. Decline ADL exhibited a higher risk of hospitalization for HF and mortality compared with non-decline ADL. A multivariate analysis revealed that decline ADL emerged as an independent risk factor of hospitalization for HF [hazard ratio (HR), 1.42; 95% confidence interval (CI): 1.01-1.96; p=0.046] and mortality (HR, 1.95; 95% CI: 1.23-2.99; p<0.01). Although 66.3% of patients with decline ADL were registered for long-term care insurance, few received daycare services (32.7%) or home-visit medical services (8.2%).
CONCLUSIONS
Decline in ADL is a predictor of hospitalization for HF and mortality in HF patients.

Identifiants

pubmed: 30598389
pii: S0914-5087(18)30367-8
doi: 10.1016/j.jjcc.2018.12.014
pii:
doi:

Types de publication

Journal Article Multicenter Study Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

522-529

Informations de copyright

Copyright © 2019 Japanese College of Cardiology. Published by Elsevier Ltd. All rights reserved.

Auteurs

Kensuke Takabayashi (K)

Department of Cardiology, Hirakata Kohsai Hospital, Osaka, Japan. Electronic address: taka410@gmail.com.

Shouji Kitaguchi (S)

Department of Cardiology, Hirakata Kohsai Hospital, Osaka, Japan.

Kotaro Iwatsu (K)

Department of Rehabilitation, Hirakata Kohsai Hospital, Osaka, Japan.

Yuko Morikami (Y)

Department of Cardiology, Hirakata Kohsai Hospital, Osaka, Japan.

Tahei Ichinohe (T)

Department of Cardiology, Hirakata Kohsai Hospital, Osaka, Japan.

Takashi Yamamoto (T)

Department of Cardiology, Hirakata Kohsai Hospital, Osaka, Japan.

Kotoe Takenaka (K)

Department of Cardiology, Hirakata Kohsai Hospital, Osaka, Japan.

Hiroyuki Takenaka (H)

Department of Cardiology, Hirakata Kohsai Hospital, Osaka, Japan.

Hiroyuki Muranaka (H)

Department of Cardiology, Hirakata Kohsai Hospital, Osaka, Japan.

Ryoko Fujita (R)

Department of Cardiology, Hirakata Kohsai Hospital, Osaka, Japan.

Osamu Nakajima (O)

Department of Cardiology, Hirakata City Hospital, Osaka, Japan.

Ryou Yokoyama (R)

Department of Cardiology, Hirakata City Hospital, Osaka, Japan.

Yuka Terasaki (Y)

Department of Internal Medicine, Arisawa General Hospital, Osaka, Japan.

Hideki Nishio (H)

Department of Cardiology, Ueyama Hospital, Osaka, Japan.

Miho Masai (M)

Department of Cardiology, Ueyama Hospital, Osaka, Japan.

Hitoshi Koito (H)

Department of Cardiology, Otokoyama Hospital, Kyoto, Japan.

Miyuki Okuda (M)

Department of Respiratory Medicine, Hirakata Kohsai Hospital, Osaka, Japan.

Hirohisa Uwatoko (H)

Department of Cardiology, Yawata Central Hospital, Kyoto, Japan.

Yoshihide Kawakami (Y)

Department of Cardiology, Nakamura Hospital, Osaka, Japan.

Sen Matsumoto (S)

Department of Cardiology, Hoshigaoka Medical Center, Osaka, Japan.

Tetsuhisa Kitamura (T)

Department of Social and Environmental Medicine, Graduate School of Medicine, Osaka University, Osaka, Japan.

Ryuji Nohara (R)

Department of Cardiology, Hirakata Kohsai Hospital, Osaka, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH